stockportfolio.pro
Cellebrite DI Ltd. (CLBT)
Technology · Software - Infrastructure · NasdaqGS
Cellebrite DI Ltd. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $270.65M | $325.11M | $401.20M | $475.68M |
| Gross profit | $219.91M | $271.88M | $338.61M | $400.50M |
| Net income | $120.81M | $-81.10M | $-283.01M | $78.33M |
| Net margin | 44.6% | -24.9% | -70.5% | 16.5% |
Source: Cellebrite DI Ltd. SEC filings (10-K).
What growth is priced into CLBT stock?
At today's market cap of $3.18B, Cellebrite DI Ltd. is priced for free-cash-flow growth of about 7.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $160.32M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Cellebrite DI Ltd. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CLBT in your portfolio →
Cellebrite DI Ltd. financial history by metric
About Cellebrite DI Ltd.
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Cellebrite DI Ltd. — frequently asked questions
What is Cellebrite DI Ltd.'s revenue?
Cellebrite DI Ltd. (CLBT) reported revenue of $475.68M for fiscal year 2025, up 18.6% from the prior year, according to its SEC filings.
Is Cellebrite DI Ltd. profitable?
Yes. CLBT earned net income of $78.33M in fiscal 2025, a net margin of 16.5%.
What is CLBT's P/E ratio?
Cellebrite DI Ltd. trades at a price-to-earnings ratio of about 45.5 based on the latest data in our nightly-refreshed cache.
How fast is Cellebrite DI Ltd. growing?
CLBT's revenue grew at roughly 20.7% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Cellebrite DI Ltd. have?
As of fiscal year 2025, CLBT carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Cellebrite DI Ltd.'s gross margin?
CLBT's gross margin was 84.2% in fiscal 2025 — gross profit of $400.50M on revenue of $475.68M.
What is Cellebrite DI Ltd.'s market cap?
Cellebrite DI Ltd. (CLBT) has a market capitalization of about $3.18B, based on the latest data in our nightly-refreshed cache.
When does Cellebrite DI Ltd.'s fiscal year end?
CLBT's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into CLBT stock?
At today's market cap of $3.18B, Cellebrite DI Ltd. is priced for free-cash-flow growth of about 7.6% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $160.32M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Cellebrite DI Ltd.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.